StockData
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd (HCM) stock

HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$14.40−0.33 (-2.24%)

Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –

HUTCHMED (China) total assets

Total assets on the balance sheet at the end of each period.

HUTCHMED (China)'s total assets was $1.74B at Jun 30, 2026. For fiscal 2025 it was $1.75B, up 37.6% from the year before. Over ten years it grew 22.5% a year on average. The highest annual figure on record is $1.75B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.75B+37.6%
FY2024Dec 31, 2024$1.27B-0.4%
FY2023Dec 31, 2023$1.28B+24.3%
FY2022Dec 31, 2022$1.03B-25.0%
FY2021Dec 31, 2021$1.37B+89.6%
FY2020Dec 31, 2020$724.12M+55.7%
FY2019Dec 31, 2019$465.12M-12.6%
FY2018Dec 31, 2018$532.12M-11.0%
FY2017Dec 31, 2017$597.93M+74.6%
FY2016Dec 31, 2016$342.44M+49.1%
FY2015Dec 31, 2015$229.60M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.74B+37.7%
Q4 FY2025Dec 31, 2025$1.75B+37.0%
Q2 FY2025Jun 30, 2025$1.78B+36.9%
Q4 FY2024Dec 31, 2024$1.27B+23.8%
Q2 FY2024Jun 30, 2024$1.26B+5.6%
Q4 FY2023Dec 31, 2023$1.28B-6.8%
Q2 FY2023Jun 30, 2023$1.30B+1.9%
Q4 FY2022Dec 31, 2022$1.03B+42.2%
Q2 FY2022Jun 30, 2022$1.19B+127.2%
Q4 FY2021Dec 31, 2021$1.37B+195.1%
Q2 FY2021Jun 30, 2021$1.27B+180.3%
Q4 FY2020Dec 31, 2020$724.12M+46.2%
Q2 FY2020Jun 30, 2020$525.56M-2.5%
Q4 FY2019Dec 31, 2019$465.12M-12.6%
Q3 FY2019Sep 30, 2019$454.09M-21.4%
Q2 FY2019Jun 30, 2019$495.21M-17.2%
Q1 FY2019Mar 31, 2019$539.30M+56.5%
Q4 FY2018Dec 31, 2018$532.12M+55.4%
Q2 FY2018Jun 30, 2018$577.94M+151.7%
Q4 FY2017Dec 31, 2017$597.93M–
Q2 FY2017Jun 30, 2017$344.70M–
Q4 FY2016Dec 31, 2016$342.44M–
Q4 FY2015Dec 31, 2015$229.60M–

More HUTCHMED (China) figures

See a number that looks wrong?